4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol has been researched along with anatabine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carmella, SG; Hatsukami, DK; Hecht, SS; Jensen, J; Kramarczuk, I; Le, C; Li, YS; Losey, L; Murphy, SE; Puumala, SS; Roe, MR; Zimmerman, CL | 1 |
Carmella, SG; Hatsukami, DK; Hecht, SS; Jensen, J; Le, C; Link, CA; Losey, L; Murphy, SE; Puumala, SS | 1 |
2 trial(s) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and anatabine
Article | Year |
---|---|
Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen.
Topics: Adult; Aged; Alkaloids; Biomarkers, Tumor; Carcinogens; Cotinine; Female; Glucuronates; Humans; Lung Neoplasms; Male; Middle Aged; Nitrosamines; Pyridines; Research Design; Smoking; Smoking Cessation; Treatment Outcome | 2004 |
A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers.
Topics: Adult; Alkaloids; Biomarkers; Carcinogens; Endpoint Determination; Environmental Exposure; Female; Ganglionic Stimulants; Humans; Male; Nicotine; Nitrosamines; Polycyclic Aromatic Hydrocarbons; Pyridines; Reproducibility of Results; Smoking; Smoking Cessation; Urinalysis | 2004 |